drugset / Trial / NCT02194283
Study to Evaluate Safety, Tolerability and Pharmacokinetics of Increasing Repeated Oral Doses of Ambroxol Lozenges in Healthy Male Volunteers
RandomizedSingle-groupDouble-blindTreatment
Summary
The main objectives of the present study are to determine pharmacokinetics of ambroxol in healthy male volunteers following repeated administration of lozenges of 20 mg ambroxol for four days
Timeline
- Start
- 2009-10
- Primary completion
- 2009-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ambroxol | Small molecule | 20 mg | Oral |
| Subject | Ambroxol | Small molecule | 40 mg | Oral |
| Subject | Ambroxol | Small molecule | 80 mg | Oral |
Indications
No indication recorded.